e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
What's new in tobacco and lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease
T. Pertseva, O. Pavlenko, O. Lycholat (Dniepropetrovsk, Ukraine)
Source:
Annual Congress 2005 - What's new in tobacco and lung disease
Session:
What's new in tobacco and lung disease
Session type:
Oral Presentation
Number:
3056
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Pertseva, O. Pavlenko, O. Lycholat (Dniepropetrovsk, Ukraine). Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease. Eur Respir J 2005; 26: Suppl. 49, 3056
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005
The role of inflammation in COPD
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Decrease of vascular endothelial growth factor in macrophages from long-term smokers
Source: Eur Respir J 2005; 25: 626-633
Year: 2005
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002
Sampling the lung fluids: peripheral biomarkers
Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Year: 2007
Smoking abstinence in patients with chronic airway obstructive disease
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006
8-isoprostane as a marker of oxidant stress in non-symptomatic cigarette smokers and COPD
Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation
Year: 2006
Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001
A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
Source: Eur Respir J 2006; 27: 293-299
Year: 2006
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004
Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
Source: Eur Respir J 2008; 31: 70-77
Year: 2008
Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid
Source: Eur Respir J 2004; 24: 964-970
Year: 2004
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Source: Eur Respir J 2005; 26: 835-845
Year: 2005
Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept